Zhejiang Zhenyuan Share Co.,Ltd. (000705.SZ)
- Previous Close
8.58 - Open
8.45 - Bid 8.57 x --
- Ask 8.58 x --
- Day's Range
8.49 - 8.69 - 52 Week Range
6.75 - 9.28 - Volume
9,317,800 - Avg. Volume
10,339,625 - Market Cap (intraday)
2.867B - Beta (5Y Monthly) 0.54
- PE Ratio (TTM)
57.20 - EPS (TTM)
0.15 - Earnings Date --
- Forward Dividend & Yield 0.06 (0.71%)
- Ex-Dividend Date Jun 7, 2024
- 1y Target Est
--
Zhejiang Zhenyuan Share Co.,Ltd. manufactures and wholesales pharmaceuticals in China and internationally. It offers Chinese herbal medicines, herbal medicine slices, and patent medicine; and pharmaceutical raw materials, chemical preparations, antibiotics, biochemical drugs, biological products, medical devices, chemical reagents, glass instruments, etc. The company also provides pharmaceutical logistics, health services, etc.; produces, wholesales, and retails medicines, pre-packaged food, and dairy products, such as infant formula milk powder. Zhejiang Zhenyuan Share Co.,Ltd. was founded in 1991 and is based in Shaoxing, China.
www.zjzy.com2,073
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: 000705.SZ
View MorePerformance Overview: 000705.SZ
Trailing total returns as of 6/10/2025, which may include dividends or other distributions. Benchmark is 000001.SS (000001.SS) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: 000705.SZ
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 000705.SZ
View MoreValuation Measures
Market Cap
2.87B
Enterprise Value
2.64B
Trailing P/E
57.28
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.86
Price/Book (mrq)
1.43
Enterprise Value/Revenue
0.76
Enterprise Value/EBITDA
35.01
Financial Highlights
Profitability and Income Statement
Profit Margin
1.49%
Return on Assets (ttm)
0.58%
Return on Equity (ttm)
2.59%
Revenue (ttm)
3.45B
Net Income Avi to Common (ttm)
51.37M
Diluted EPS (ttm)
0.15
Balance Sheet and Cash Flow
Total Cash (mrq)
503.33M
Total Debt/Equity (mrq)
13.56%
Levered Free Cash Flow (ttm)
36.19M